1.61

3.59% -0.06

After Hours: 1.28 -0.33 -20.50%

Pulmatrix Inc (PULM)

Overview News Price History Financials Discussions Forecast Stock Split

Pulmatrix Inc stock is traded at $1.61, with a volume of 11,937. It is down -3.59% in the last 24 hours and up +0.63% over the past month. Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Previous Close:

$1.67

Open:

$1.64

24h Volume:

11,937

Relative Volume:

0.42

Market Cap:

$5.88M

Revenue:

$3,000

Net Income/Loss:

$-4.53M

P/E Ratio:

-1.2992

EPS:

-1.2392

Net Cash Flow:

$-4.69M

1W Performance:

+11.81%

1M Performance:

+0.63%

6M Performance:

-24.06%

1Y Performance:

-63.49%

1-Day Range:

$1.60

$1.6968

1-Week Range:

$1.39

$1.7761

52-Week Range:

$1.16

$5.498

Pulmatrix Inc Stock (PULM) Company Profile

Name

Pulmatrix Inc

Sector

Healthcare (1067)

Industry

Biotechnology (595)

Phone

(888) 355-4440

Address

945 CONCORD STREET, FRAMINGHAM, MA

Employee

Twitter

@pulmatrix_inc

Next Earnings Date

2026-10-15

Latest SEC Filings

PULM's Discussions on Twitter

Compare PULM vs VRTX, REGN, MRNA, ARGX, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PULM Pulmatrix Inc	1.61	5.88M	3,000	-4.53M	-4.69M	-1.2392
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Pulmatrix Inc Stock (PULM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-18	Initiated	H.C. Wainwright	Buy

Pulmatrix Inc Stock (PULM) Latest News

Sep 25, 2026

Pulmatrix Files Definitive Proxy for Merger with Eos SENOLYTIX, Outlines Share Issuance and Ownership Structure - Kalkine Media

Sep 25, 2026

Pulmatrix Sets Special Meeting to Approve Merger With Eos SENOLYTIX - tipranks.com

Sep 25, 2026

One holder is expected to control over 50% of voting power after Pulmatrix (PULM)'s proposed Eos merger. - Stock Titan

Sep 25, 2026

Sep 23, 2026

One exhibit removed: Pulmatrix (PULM) amends its business combination paperwork. - Stock Titan

Sep 23, 2026

Sep 22, 2026

Form 4 Pulmatrix Inc For: 22 September - Investing.com India

Sep 22, 2026

Form 4 Pulmatrix Inc For: 22 September By Investing.com - Investing.com Canada

Sep 22, 2026

New MTXL ticker planned if Pulmatrix (NASDAQ: PULM) investors approve Eos merger - Stock Titan

Sep 22, 2026

Sep 17, 2026

Pulmatrix (PULM) investors face 6% stake in Eos merger - stocktitan.net

Sep 17, 2026

Sep 15, 2026

Pulmatrix Inc (NASDAQ: PULM) Share Price, PULM Stock News, PULM Share Price & Updates - kalkine.com.au

Sep 15, 2026

Sep 04, 2026

Pulmatrix (NASDAQ: PULM) warns it may liquidate if Eos merger fails - Stock Titan

Sep 04, 2026

Sep 01, 2026

Pulmatrix (PULM) Holds Steady at $1.47 as Shares Trade Between Key Support and Resistance LevelsNegative Gamma - vinanet.vn

Sep 01, 2026

Aug 19, 2026

Pulmatrix | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactionsmoomoo - Moomoo

Aug 19, 2026

Aug 16, 2026

Precision Trading with Pulmatrix Inc. (PULM) Risk Zones - Stock Traders Daily

Aug 16, 2026

Aug 15, 2026

PULM Q2 2025 Earnings: Net Loss of $0.42 Per Share as Stock Moves 1.99Earnings Outlook Update - vinanet.vn

Aug 15, 2026

Pulmatrix (PULM) Gains 1.99% to $1.54 as Stock Holds Above Key SupportLong Term Entry Picks - vinanet.vn

Aug 15, 2026

Aug 14, 2026

PULM Q2 2025 Earnings: Loss of $0.42 Per Share Amid 3.97% Stock GainSubscription Growth Report - vinanet.vn

Aug 14, 2026

Aug 13, 2026

Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com Australia

Aug 13, 2026

Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - Morningstar

Aug 13, 2026

Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger - TradingView

Aug 13, 2026

Pulmatrix posts Q2 2026 net loss $1.04M, cash $2.2M; files Form S-4 for Eos merger - TradingView

Aug 13, 2026

Pulmatrix, Inc. Q2 2026: Net loss $1.05M, EPS $(0.29) — 10-Q Summary - TradingView

Aug 13, 2026

PULM: Q2 2026 featured lower expenses, a narrowed net loss, and progress toward the Eos merger - TradingView

Aug 13, 2026

Press Release: Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - Moomoo

Aug 13, 2026

Aug 08, 2026

Pulmatrix (PULM) Holds at $1.66 as Trading Range Between $1.58 and $1.74 Defines ActionLast Point Support - vinanet.vn

Aug 08, 2026

Aug 07, 2026